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Abstract: The greatest burden of cardiovascular disease is now carried by developing countries with
cardiometabolic conditions such as metabolic syndrome, obesity and inflammation believed to be the
driving force behind this epidemic. Dietary fiber is known to have protective effects against obesity,
type 2 diabetes, cardiovascular disease and the metabolic syndrome. Considering the emerging
prevalence of these cardiometabolic disease states across the epidemiologic transition, the objective
of this study is to explore these associations of dietary fiber with cardiometabolic risk factors in four
countries across the epidemiologic transition. We examined population-based samples of men and
women, aged 25–45 of African origin from Ghana, Jamaica, the Seychelles and the USA. Ghanaians
had the lowest prevalence of obesity (10%), while Jamaicans had the lowest prevalence of metabolic
syndrome (5%) across all the sites. Participants from the US presented with the highest prevalence
of obesity (52%), and metabolic syndrome (22%). Overall, the Ghanaians consumed the highest
dietary fiber (24.9 ± 9.7 g), followed by Jamaica (16.0 ± 8.3 g), the Seychelles (13.6 ± 7.2 g) and the
lowest in the USA (14.2 ± 7.1 g). Consequently, 43% of Ghanaians met the fiber dietary guidelines
(14 g/1000 kcal/day), 9% of Jamaicans, 6% of Seychellois, and only 3% of US adults. Across all sites,
cardiometabolic risk (metabolic syndrome, inflammation and obesity) was inversely associated with
dietary fiber intake, such that the prevalence of metabolic syndrome was 13% for those in the lowest
quartile of fiber intake, compared to 9% those in the highest quartile of fiber intake. Notably, twice as
many of participants (38%) in the lowest quartile were obese compared to those in the highest quartile
of fiber intake (18%). These findings further support the need to incorporate strategies and policies to
promote increased dietary fiber intake as one component for the prevention of cardiometabolic risk
in all countries spanning the epidemiologic transition.
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Nutrients 2018, 10, 628; doi:10.3390/nu10050628 www.mdpi.com/journal/nutrients
Nutrients 2018, 10, 628 2 of 12
1. Introduction
The high prevalence of cardiometabolic disease, including cardiovascular disease (CVD),
metabolic syndrome, obesity and type 2 diabetes, has been well documented in developed
countries [1–3]. These non-communicable diseases are increasing in prevalence in developing countries
with rates approaching those of developed countries [4–6]. Here, we discuss these diseases as they
relate to inflammation, obesity, and metabolic syndrome, a cluster of risk factors that elevate the risk of
future CVD and includes raised fasting plasma glucose, abdominal obesity, and blood pressure [7].
The co-occurrence of these CVD risk factors characteristic of metabolic syndrome is believed to be the
impetus driving the increasing CVD global prevalence.
Chronic low-grade inflammation is a pathological feature of chronic conditions including type 2
diabetes, metabolic syndrome, CVD and non-alcoholic fatty liver disease (NAFLD) [8,9]. Similarly, the
key inflammatory marker, C-reactive protein (CRP), has been linked to insulin resistance, hypertension,
development of type 2 diabetes and metabolic syndrome [10–12]. Chronic inflammation has been
associated with poor lifestyle behavior such as dietary habits [13]. Diets high in dietary fiber
(>30 g/day) have been shown to reduce levels of CRP [14], while inflammation characterized by
serum levels of between 1 and 10 mg/L are associated with an increased risk of the development of
CVD [15]. Notably, CRP has been well described as an independent risk marker for CVD [16].
Globally, as many as 75% of deaths due to coronary heart disease occur in developing
countries [17]. The increasing prevalence of coronary heart disease in developing countries may
be in part due to the epidemiologic transition [18], which describes the shift towards an industrialized
consumer society, environmental, social and structural changes occur that may result in changes in
morbidity and mortality patterns. In fact, over the last two decades, there has been a transition in
the leading cause of death in developed countries from infectious etiologies to CVD and cancer [19].
Adverse lifestyle changes, such as increases in body weight, blood pressure, triglycerides, cholesterol
levels, and diabetes prevalence have all been shown to contribute to increased exposure to CVD
risk [20,21]. Notably, this transition has been associated with nutrition changes, due to the globalization
of food production leading to a shift from traditional low fat, complex carbohydrate rich diets to the
increased consumption of energy-dense, micronutrient and fiber poor foods [21].
Increasing dietary fiber intake may be one component of a multi-faceted approach to prevent
cardiometabolic disease. Previous studies have found fiber to have protective effects against these
related chronic health conditions, such as obesity [22], type 2 diabetes [23], cardiovascular disease [24]
and metabolic syndrome [25,26]. Therefore, the objectives of this study are to examine the associations
between dietary fiber and metabolic syndrome, inflammation and obesity in four countries of African
origin spanning the epidemiologic transition.
2. Materials and Methods
2.1. Study Population and Ethics Approval
Initially, 2500 participants of African-descent aged 25–45 years from each of five countries:
Ghana, Jamaica, South Africa, the Seychelles and the United States were enrolled in the Modelling
the Epidemiologic Transition Study (METS) [27]. Briefly, five hundred participants, approximately
50% of whom are female, were enrolled in each of five study sites: rural Ghana, peri-urban South
Africa, mixed urban/rural Seychelles, urban Jamaica and metropolitan Chicago. All participants, with
the exception of the Seychelles, were of African descent. The five sites represented a range of social
and economic development as defined by the UN Human Development Index (HDI) 2010; a rural
Nkwantakese site in Ghana defined as a low HDI, and urban South African site as middle HDI and
urban Seychelles and Jamaica as high HDI and a suburban Chicago site in the United States as a very
high HDI country [28]. For the current analysis, however, due to concerns in the quality of dietary
data from South Africa, this site was dropped. Baseline measures were conducted between January
2010 and December 2011. A detailed description of recruitment, measures and protocols has been
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previously published [27]. Approximately 50% of participants were female. The participant pool
provided a range of body sizes with BMIs of participants from Ghana at a low of 24 kg/m2 to a high of
31 kg/m2 from the USA.
Persons with obvious infectious disease, pregnant or lactating women and HIV positive
individuals, as well as individuals with conditions preventing them from engaging in normal physical
activity such as severe arthritis and lower extremity disability, were excluded from the study.
The protocol for METS was approved by the Institutional Review Board of Loyola University
Chicago, IL, USA (LU#200038); the Committee on Human Research Publication and Ethics of Kwame
Nkrumah University of Science and Technology, Kumasi, Ghana; the Research Ethics Committee of the
University of Cape Town, South Africa; the Board for Ethics and Clinical Research of the University
of Lausanne, Switzerland; and the Ethics Committee of the University of the West Indies, Kingston,
Jamaica; Written informed consent was obtained from all participants.
2.2. Dietary Intake
Each study participant completed two 24-h recalls using the multiple pass method [29–31], the first
at the initial baseline visit and the second approximately 1 week later. In addition, 24-h recalls were
recorded manually by trained interviewers and later entered electronically at the coordinating center
at Loyola University Chicago. Dietary analysis was performed using the Nutrient Data System for
Research (NDSR; University of Minneapolis, MN, USA) [29–31]. Food ingredient identification and
portion size estimation were approximated from photographs of local foods at each site following
methodology developed by the Medical Research Council South Africa [32]. The primary endpoint
measures of interest were total energy intake and macronutrient composition. We also estimated the
number of participants within each site meeting the Institute of Medicine recommendation that adults
consume 14 g fiber/1000 kcal [33].
2.3. Biochemical Measures
Participants were asked to fast from the evening prior to the baseline clinic examination. Fasting
blood samples were drawn for analysis of adipose-related hormones and adipocytokines, glucose,
insulin, lipids, and albumin. The blood samples were processed and plasma or serum separated
within two hours of collection and stored at −80 ◦C in the laboratory at each study site. Fasting
plasma glucose was measured using the glucose oxidase method at each site at the time of collection.
Insulin, total ghrelin, leptin and adiponectin from all sites were measured using radioimmunoassay
kits (Linco Research, Inc., St. Charles, MO, USA) at the departmental laboratory at Loyola University
Chicago. All remaining assays were conducted at the Zentrum fῦr Lambormedizin, Leiter Klinische
Chemie und Hämatologie, St. Gallen, Switzerland.
2.4. Physical Activity Measurement
Physical activity (PA) was assessed using Actical accelerometers (Phillips Respironics, Bend,
OR, USA) as previously described [34,35]. The Actical monitor was worn over an 8-day period,
including during sleep. Raw data downloaded were first passed through a SAS) macro program [36]
designed to infer non-wear time from 90 or more minutes of continuous zero activity counts. A valid
day of PA monitoring was defined as one having 10 or more hours of wear time and participant files
were included if they contained ≥4 or more valid days. Using the same protocol employed by the
National Center for Health Statistics for the analysis of accelerometry data in the continuous National
Health and Nutrition Examination Survey [37], minutes defined as comprising moderate, vigorous or
moderate plus vigorous activity are presented as the total time in minutes (min) per day.
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2.5. Clinical Outcomes
Metabolic syndrome was defined according to the Adult Treatment Panel III criteria [38,39]
where individuals with at least three of the following cardiometabolic components were classified as
having metabolic syndrome:
1. Waist circumference >102 cm in males and >88 cm in females;
2. Elevated blood pressure (≥130/85 mm Hg), or receiving treatment;
3. Hypertriglyceridemia (≥150 mg/dL), or receiving treatment;
4. Low high-density lipoprotein (HDL) cholesterol (<40 mg/dL in males and <50 mg/dL in females),
or receiving treatment; and
5. Elevated fasting plasma glucose (≥100 mg/dL), or receiving treatment.
Inflammation was defined as C-reactive protein concentrations >3.0 mg/L [40,41]. Individuals
with a body mass index ≥30 kg/m2 were defined as obese [42].
2.6. Statistical Analyses
Participant characteristics and cardiometabolic risk factors were summarized using means ±
standard deviations (SD), after being examined for normality. Proportions were calculated and
presented as n (%) for dichotomous variables. Fiber quartiles were determined for each site as well as
across all sites based on mean individual dietary fiber intake (g/day). Comparison of cardiometabolic
risks by fiber quartiles at each site was performed by Pearson’s chi-squared test with statistical
significance noted for p ≤ 0.05. Multi-variable logistic regression was performed with the outcomes of
metabolic syndrome, inflammation and obesity stratified by dietary fiber quartile after adjusting for
age, gender, energy intake and smoking. Statistical analyses were performed using Stata (version 12,
Manufacturer, College Station, TX, USA).
3. Results
Data from a total of 1940 participants from four sites were included in this analysis. Descriptive
characteristics of participants, by site, are presented in Table 1. The mean age of participants was
similar across all sites ranging from 34.2 ± 6.7 years in Ghana to 36.2 ± 5.6 years in Seychelles. Weight,
height and subsequent body mass index varied greatly across all sites with Ghanaians being shorter
(162.6 ± 8.2 cm), lighter (63.5 ± 11.5 kg) and having lower body mass indices (24.1 ± 4.5 kg/m2)
compared to all other sites. Conversely, US participants were the tallest (169.9 ± 9.0 cm), heaviest
(91.9 ± 24.2 kg) and had the highest body mass indices (31.9 ± 8.4 kg/m2) across all the sites.
Waist circumference measures followed the same trend with Ghana on the lowest end of the range
(81.2 ± 12.1 cm) and US participants on the highest end (99.6 ± 20.4 cm). Similarly, systolic and
diastolic blood pressures were the lowest in Ghana (113.90 ± 14.8 mmHg and 67.1 ± 11.3 mmHg,
respectively) and highest in the USA (122.6 ± 16.3 mmHg and 80.5 ± 12.8 mmHg, respectively).
The US participants had the highest mean values of all biochemical measures of cardiometabolic
risk factors (total cholesterol, HDL-C, triglycerides, blood glucose and CRP). The lowest mean values
of biochemical measures of cardiometabolic risk factors were distributed amongst the lower and mid
HDI countries with lowest total cholesterol and HDL-C values observed in Ghana, triglycerides and
blood glucose in Jamaica and CRP in Seychelles.
The highest proportion of smokers were from the US (46.3%) and the lowest proportion of
smokers were from Ghana (2.7%). Participants from the US accumulated the lowest amount of daily
moderate-to-vigorous PA (23.2 ± 28.9 min/day) compared to the Ghanaians who spent more than 30
mins/day in moderate-to-vigorous activity.
Habitual dietary intake data are summarized in Table 2. The US participants consumed a diet that
was the most energy rich (2294 ± 889.3 kcal/day) compared to the three sites. They also consumed the
lowest amount of total dietary fiber (14.2 ± 7.1 g/day), and insoluble dietary fiber (9.5 ± 5.4 g/day).
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Conversely, Ghanaians consumed the highest dietary fiber (24.9 ± 9.7 g/day) and insoluble dietary
fiber (18.8 ± 7.5 g/day). Overall, 43% of Ghanaians met the Institute of Medicine (IOM) fiber guideline
[>14 g fiber/1000 kcal/day, [33]], compared to only 9% of Jamaicans, 6% of participants from Seychelles,
and only 3% of participants from the US. Overall, the Ghanaian diet was low in fat and protein and high
in the proportion of carbohydrates, with 21.6% of their energy coming from fat, 11.9% from protein and
65.9% from carbohydrates. In contrast, the US diet was high in fat and protein and low in carbohydrates
with 36.6% of their energy from fat, 15.6% from protein and 45.8% from carbohydrates. Interestingly,
protein intake (18.4 ± 4.7% energy intake) was highest among participants from Seychelles, reflecting
the large contribution of seafood from this island nation.
Table 1. Descriptive characteristics of study population by site.
Ghana Jamaica Seychelles United States
N = 489 N = 402 N = 484 N = 444
Demographics
Female (n, %) 287 (58.7) 244 (60.7) 261 (53.9) 228 (51.4)
Age (year) 34.2 ± 6.8 34.4 ± 6.1 36.2 ± 5.6 35.2 ± 6.3
Anthropometrics
Weight (kg) 63.5 ± 11.5 75.9 ± 17.1 75.8 ± 17.0 91.9 ± 24.2
Height (cm) 162.6 ± 8.2 169.6 ± 9.2 167.1 ± 8.8 169.9 ± 9.0
Body Mass Index (kg/m2) 24.1 ± 4.5 26.6 ± 6.4 27.1 ± 5.6 31.9 ± 8.4
Waist Circumference (cm) 81.2 ± 12.1 86.1 ± 14.2 88.7 ± 12.0 99.6 ± 20.4
Systolic Blood Pressure (mmHg) 113.9 ± 14.8 118.4 ± 14.2 116.2 ± 14.7 122.6 ± 16.3
Diastolic Blood Pressure (mmHg) 67.1 ± 11.3 71.7 ± 11.3 73.0 ± 10.7 80.5 ± 12.8
Biochemical Measures
Cholesterol (mg/dL) 161.4 ± 35.3 162.8 ± 33.9 170.9 ± 35.4 181.1 ± 38.4
HDL-C (mg/dL)
Ratio total cholesterol to HDL
46.0 ± 14.4
3.8 ± 1.7
46.5 ± 12.1
3.7 ± 1.0
47.7 ± 12.8
3.9 ± 1.2
50.8 ± 14.6
3.8 ± 1.1
Triglycerides (mg/dL) 82.0 ± 40.3 73.2 ± 36.3 79.8 ± 60.6 97.3 ± 57.4
Blood glucose (mg/dL) 100.3 ± 12.2 93.1 ± 9.4 100.9 ± 29.5 103.5 ± 35.5
CRP (mg/dL) 4.7 ± 13.3 4.2 ± 6.3 3.1 ± 4.5 6.0 ± 11.0
Lifestyle Habits
Smoker or ex-smoker (n, %)
Moderate-to-vigorous PA (min/day)
13 (2.8)
34.3 ± 22.6
101 (25.1)
23.3 ± 19.3
95 (19.6)
28.9 ± 20.9
205 (46.3)
23.3 ± 28.9
Table 2. Dietary analysis of study population by site.
Ghana Jamaica Seychelles United States
N = 489 N = 402 N = 484 N = 444
Energy (kcal) 1849 ± 495.7 1930 ± 590.5 1844 ± 590.9 2294 ± 889.3
% Energy from fat 21.6 ± 9.2 25.7 ± 6.6 28.4 ± 7.7 28.4 ± 7.7
% Energy from saturated fat 7.1 ± 4.1 9.4 ± 4.1 8.4 ± 2.9 11.8 ± 2.9
%Energy from monounsaturated fat 8.2 ± 3.7 8.6 ± 2.6 8.9 ± 3.0 13.6 ± 3.1
% Energy from polyunsaturated fat 4.6 ± 2.5 5.5 ± 2.1 8.6 ± 3.4 7.9 ± 2.8
% Energy from carbohydrates
% Energy from protein
65.9 ± 10.4
11.9 ± 4.0
58.6 ± 8.4
14.7 ± 3.9
51.3 ± 9.4
18.4 ± 4.7
45.8 ± 9.4
15.6 ± 4.1
Meeting 14 g/1000 kcal (n, %) 208 (42.5) 35 (8.7) 28 (5.8) 14 (3.2)
Dietary fiber (g) 24.9 ± 9.7 16.0 ± 8.3 13.6 ± 7.2 14.2 ± 7.1
Soluble fiber (g) 6.1 ± 2.8 4.8 ± 2.6 3.9 ± 2.2 4.6 ± 2.4
Insoluble dietary fiber (g) 18.8 ± 7.5 11.6 ± 6.1 9.6 ± 5.4 9.5 ± 5.4
Ratio soluble to insoluble dietary fiber 0.3 ± 0.1 0.4 ± 0.2 0.4 ± 0.2 0.6 ± 0.3
Meeting 14 g/1000 kcal (n, %) 208 (42.5) 35 (8.7) 28 (5.8) 14 (3.2)
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3.1. Cardiometabolic Risk Factors across the Epidemiologic Transition
The US participants consistently presented with the greatest prevalence of cardiometabolic
risk factors, including metabolic syndrome (22%), inflammation (45%) and obesity (52%). While
Jamaicans had the lowest levels of metabolic syndrome (5%), they presented with unexpectedly high
levels of inflammation (35%) and obesity (31%). Ghanaians presented with the lowest proportion of
inflammation (22%) and obesity (10%). A comparison of cardiometabolic risk by site can be seen in
Figure 1.
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Figure 1. Comparison of prevalence of cardiometabolic risk by site. Metabolic syndrome was
defined according to the Adult Treatment Panel III criteria [38,39] where individuals had at least
three cardiometabolic components. Inflammation was defined as C-reactive protein concentrations
>3.0 mg/L [40,41]. Individuals with a body mass index ≥30 kg/m2 were defined as obese [42].
3.2. he ssociation of Dietary Fiber Intake on Cardiometabolic Risk Factors across the Epidemiologic Transition
The prevalence of cardiometabolic risk factors was analyzed by chi-square analysis comparing
the lowest fiber quartile (Q1) to the highest fiber quartile (Q4) specific to each site to deter ine the
effect of dietary fiber intake on cardiometabolic risk at each site. The trend for t e lower prevale ce of
cardiometabolic risk factors with increased dietary fiber was seen for most cardiometabolic conditions
in most sites, apart from inflammation in Ghana an Jamaica and metabolic syndrome in the Seychelles.
However, it should be noted, that differences in the prevalence of the cardiometabolic risk factors and
fiber quartiles were modest with statistical significance achieved only in the prevalence of inflammation
in the Seychelles and the USA and metabolic syndrome in the USA.
Mean dietary fiber intake across all sites was 17.3 g/day. The compariso of cardiometabolic risk
factors by ietar fi er quartiles across all sites followed the trend seen by inter-site comparison.
Overall, cardiometabolic risk decreased with increasing dietary fiber intake. For ex mple,
the prevalence f metabolic syndrome in participa ts from the lowest quartile was 12.5% co ared to
the 9.0% in the highest quartile (p = 0.089), as seen in Table 3. Similarly, 38.0% of participants from the
lowest quartile presented with increased infl mmatory CRP, compared to 23.8 of participants in the
highest quartile (p < 0.001). Finally, approximately 38.2% of participants in the lowest quartile of fiber
i take were obese, com ared to 17.6% in the highest quartile of fiber intake (p < 0.001).
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Table 3. Comparison of cardiometabolic risks by fiber quartiles at each site, N (%).
Ghana Jamaica Seychelles USA Across All Sites
n = 246 n = 200 n = 242 n = 222 n = 942
Q1 Q4 b Q1 Q4 c Q1 Q4 d Q1 Q4 e Q1 Q4 f
Metabolic syndrome 9 (7.3) 8 (6.5) 10 (10.0) 6 (6.0) 8 (6.6) 12 (9.9) 30 (27.0) 15 (13.5) * 57 (12.5) 41 (9.0)
Inflammation 26 (23.0) 29 (24.8) 27 (30.3) 34 (36.6) 33 (31.1) 22 (19.5) * 51 (51.0) 39 (37.5) * 154 (38.0) 103 (23.8) *
Obesity 12 (9.8) 10 (8.1) 34 (34.0) 27 (27.0) 39 (32.2) 30 (24.8) 56 (50.5) 54 (48.7) 173 (38.0) 80 (17.6) *
* p ≤ 0.05; a Q1 represents the lowest quartile of fiber intake, and Q4, the highest. b Q1 < 17.84, Q4 > 30.88; c Q1 < 9.92, Q4 > 19.80 d Q1 < 8.99, Q4 > 17.18; e Q1 < 8.78, Q4 > 17.55; f Q1 <
10.34, Q4 > 22.10.
In Table 4, the adjusted multivariate logistic regression models demonstrate an inverse relationship between dietary fiber intake and cardiometabolic risk.
After adjusting for age, gender, energy intake, PA and smoking, increasing fiber intake is associated with protection from the metabolic syndrome. Specifically,
participants who consumed more than 22.1 g/day of fiber were 29% less likely to present with metabolic syndrome, compared to participants consuming less
than 10.3 g/day of dietary fiber. Similarly, people consuming greater than 22.1 g/day of fiber were 47% less likely to have elevated CRP values, compared to
those only consuming less than 10.3 g/day of dietary fiber. Finally, participants consuming more than 22.1 g/day were 66% less likely to be obese, compared to
those consuming less than 10.3 g/day of dietary fiber.
Table 4. Adjusted odds ratios for cardiometabolic risk factors, based on quartiles of dietary fiber intake in four countries across the epidemiologic transition 1.
Quartiles of Total Fiber Metabolic Syndrome Inflammation Obesity
0.0–10.3 g (Q1) 1 1 1
10.3–15.1 g (Q2) 1.0 (0.7–1.5) 0.9 (0.7–1.3) 0.9 (0.7–1.2)
15.1–22.1 g (Q3) 0.5 (0.3–0.8) * 0.7 (0.5–0.9) * 0.6 (0.4–0.8) *
>22.1 g (Q4) 0.7 (0.4–1.2) 0.5 (0.4–0.8) * 0.4 (0.2–0.5) *
1 Multivariate model adjusted for age, gender, energy intake, physical activity and smoking. * p ≤ 0.05.
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4. Discussion
This study investigated the association of cardiometabolic risk factors and dietary fiber intake
in four diverse populations spanning the epidemiologic transition. The US is considered a very high
HDI designation, and the self-reported diets consist largely of processed and fast foods that are energy
dense, of low nutritional value and very low in fiber content. The data shown here illustrate the
nutritional transition across the epidemiologic transition [43,44]. Historically, the rapid modernization
seen during the formation of the People’s Republic of China resulted in dramatic changes to diet,
physical activity and obesity-related changes similar to that seen in developing countries [44]. One such
diet change was the transition towards refined grains and away from high fiber containing coarser
grains that involved a shift from traditional diets to processed high-fat and sugary foods. Similar
results can be seen in developing countries [44–47].
The 2015 Dietary guidelines for Americans recommend that females 31–50 years of age is
25.2 g/day and 30.8 g/day for males of the same age [48], while the Institute of Medicine recommends
that adults consume >14 g fiber/1000 kcal [33]. The data presented here show that dietary fiber
intake is well below recommended amounts and this is particularly evident in the US participants,
where mean dietary fiber intake was 14.2 ± 7.1 g/day, with only 3% of the study population meeting
the Institute of Medicine fiber intake guideline. This is in line with previously reported USA estimates
for dietary fiber intake of 15.7–17.0 g/day [49] for non-Hispanic blacks, who only consumed about
14 g/day, well below the recommended daily fiber intake. The Ghanaian diet had the highest dietary
fiber intake (24.9 ± 9.7 g/day) due to fiber rich foods like cassava (eaten as banku or fufu) eaten as
staples with most meals in rural Ghanaian villages. Despite this, only 43% of Ghanaians met the
Institute of Medicine fiber intake guideline of >14 g fiber/1000 kcal.
In our study, we found a heterogeneous pattern of cardiometabolic risk factors in the four
populations spanning the epidemiologic transition. Collectively, the prevalence of cardiometabolic
risk factors are lowest in Ghana (lowest HDI) and highest in the USA (highest HDI) compared
to the other sites analyzed in this study. When comparing the prevalence of cardiometabolic risk
factors between participants consuming either the lowest or highest daily dietary fiber across all
sites, a significant association is seen for higher inflammation, indicated by elevated CRP levels and
obesity in the participants with the lowest daily fiber intake. Although no statistical significance
was reached between indicators of metabolic syndrome and dietary fiber quartiles, a similar trend
was observed. Similarly, non-significant trends were observed within each site. This could be due
to sampling methods where intra-site study participants were geographically very close (within the
same communities or villages) and therefore represented very similar lifestyle exposures and risk
factors. This resulted in little variability within the site. However, overall, the findings from this study
corroborate with many other studies, finding that dietary fiber may have a protective effect against
cardiometabolic risk [22–26]. In our study, participants with the highest daily dietary fiber intakes
had significantly lower odds for cardiometabolic risk, after adjusting for other known lifestyle risk
factors. Notably, we have shown that consuming more dietary fiber is associated with a decreased
odds of cardiometabolic risk, and that the odds of metabolic syndrome, inflammation and obesity
decrease with a higher fiber intake (>22 g), after accounting for the effects age, gender, smoking,
low PA, and energy intake (Table 4). The implications of this are that concerted efforts should be made
to increase fiber intake, and that following the recommended amount is optimal for cardiometabolic
risk reduction [48].
This study represents one of a few studies examining cardiometabolic risk across multiple sites
spanning the epidemiological transition, particularly in people of African origin. Standardized
questionnaires, protocols, analysis and methodology allow us to make these comparisons across all
sites. However, we recognize limitations to our study. Firstly, while dietary fiber intake is the main
focus of the current paper, it is likely only one modifiable component of a multi-faceted approach
to prevent and treat cardiometabolic risk. Other important dietary aspects may also contribute to
cardiometabolic risk [50]. For example, the US participants not only consumed the lowest daily amount
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of fiber, but they also consumed the greatest number of calories, and had the greatest proportion
of energy from fat. In addition, they also accumulated the least amount of moderate-to-vigorous
daily PA, and had the most smokers. Taken together, it is therefore not surprising that the US cohort
presented with the greatest cardiometabolic disease prevalence. However, these other factors were
adjusted for in the analysis, and dietary fiber intake remained significantly inversely associated with
cardiometabolic outcomes. Secondly, within in each site, the sample size was relatively small, and not
necessarily representative of that country as a whole. Thirdly, the study does not include the elderly
who are at increased risk of cardiometabolic disease. However, the narrow range used in this study
allows for direct comparisons across sites. Fourth, dietary information was dependent on self-report
on 24 h recall. It is well known that this frequently results in underestimation of portion size and recall
bias. Finally, this study focused only on total dietary fiber; however, the type of dietary fiber may be
important to its association with cardiometabolic risk.
5. Conclusions
This study has shown that dietary fiber intake varies across the epidemiologic transition, and is
inversely associated with cardiometabolic risk factors, which similarly range from the least prevalent in
the lower HDI counties (Ghana) to the greatest prevalence in higher HDI country (US). The significant
association between these risk factors and dietary fiber intake suggest that this relationship may be
dose dependent. These findings further support the need to incorporate strategies and policies to
promote increased dietary fiber intake as one component for the prevention of cardiometabolic risk in
all countries spanning the epidemiologic transition.
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